Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation-Reference-Cited by-同舟云学术

Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation

Published:2003-01 Issue:1 Volume:459 Page:83-95
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Darmani Nissar A.,Sim-Selley Laura J.,Martin Billy R.,Janoyan Jano J.,Crim Jennifer L.,Parekh Bavita,Breivogel Christopher S.

Publisher

Elsevier BV

Subject

Pharmacology

Reference35 articles.

1. Neurobiology of marijuana abuse;Abood;Trends Pharmacol. Sci.,1992

2. The functional neuroanatomy of brain cannabinoid receptors;Breivogel;Neurobiol. Dis.,1998

3. Cannabinoid signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation and adenylate cyclase inhibition;Breivogel;J. Pharmacol. Exp. Ther.,2000

4. Regional differences in cannabinoid receptor/G protein coupling in rat brain;Breivogel;J. Pharmacol. Exp. Ther.,1997

5. Cannabinoid receptor agonist efficacy for stimulating [35S] GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity;Breivogel;J. Biol. Chem.,1998

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor;International Journal of Molecular Sciences;2024-05-03

2. The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential;Life Sciences;2023-09

3. A re-consideration of neural/receptor mechanisms in chemotherapy-induced nausea and vomiting: current scenario and future perspective;Pharmacological Reports;2023-08-16

4. Therapeutic uses of Cannabis sativa L. Current state and future perspectives;Current Applications, Approaches, and Potential Perspectives for Hemp;2023

5. Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models;Behavioural Pharmacology;2022-01-17